Tapewire

Nasdaq · USD

PETS

PETMED EXPRESS INC

Export transactions ↓
Tapewire entity
7326
SEC CIK
0001040130
Parsed reports
178

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202610
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 28, 2026 Filed Sep 29, 2026 20:36 UTC
Willard Jeffrey AllenDirector · CEO and President
GrantPerformance Share Units · Derivative 250,000 $0.00 $0.00
Disclosure

SEC source: 0001040130-26-000064 · wk-form4_1790714172.xml · derivative · entry 2

Willard Jeffrey Allen · CIK 0002155835 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2029-09-28

F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029.

F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029.

Read SEC document
September 28, 2026 Filed Sep 29, 2026 20:36 UTC
Willard Jeffrey AllenDirector · CEO and President
GrantCommon Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0001040130-26-000064 · wk-form4_1790714172.xml · nonDerivative · entry 1

Willard Jeffrey Allen · CIK 0002155835 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Inducement Incentive Plan that will vest as to one-third of the granted shares on each of the first three anniversaries of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment.

Read SEC document
September 17, 2026 Filed Sep 21, 2026 12:58 UTC GrantCommon Stock 49,923 $0.00 $0.00
Disclosure

SEC source: 0001040130-26-000051 · wk-form4_1789995525.xml · nonDerivative · entry 1

Elkeles Tamar · CIK 0001750083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,923

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors.

Read SEC document
August 11, 2026 Filed Aug 12, 2026 20:19 UTC
LaCamp JamesDirector
GrantCommon Stock 55,555 $0.00 $0.00
Disclosure

SEC source: 0001040130-26-000034 · wk-form4_1786565948.xml · nonDerivative · entry 1

LaCamp James · CIK 0001794194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,421

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.

Read SEC document
August 11, 2026 Filed Aug 12, 2026 20:15 UTC GrantCommon Stock 55,555 $0.00 $0.00
Disclosure

SEC source: 0001789515-26-000003 · wk-form4_1786565738.xml · nonDerivative · entry 1

Mennen Justin L. · CIK 0001789515 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,274

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.

Read SEC document
August 11, 2026 Filed Aug 12, 2026 20:17 UTC GrantCommon Stock 55,555 $0.00 $0.00
Disclosure

SEC source: 0002064538-26-000002 · wk-form4_1786565850.xml · nonDerivative · entry 1

Batushansky Peter · CIK 0002064538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,928

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.

Read SEC document
August 11, 2026 Filed Aug 13, 2026 21:09 UTC
Campbell Leslie C.G.Director · Interim CEO and President
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001686078-26-000004 · wk-form4_1786655379.xml · nonDerivative · entry 1

Campbell Leslie C.G. · CIK 0001686078 · Director · Interim CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,000

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that will vest as to all shares on the first anniversary of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment.

Read SEC document
June 26, 2026 Filed Jun 26, 2026 20:07 UTC
KRULIK DOUGLASCAO and Interim CFO
GrantPerformance Share Units · Derivative 32,500 $0.00 $0.00
Disclosure

SEC source: 0002035815-26-000002 · wk-form4_1782504439.xml · derivative · entry 2

KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 32,500 shares

Expires 2028-12-31

F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2028.

F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2028.

Read SEC document
June 26, 2026 Filed Jun 26, 2026 20:07 UTC
KRULIK DOUGLASCAO and Interim CFO
GrantCommon Stock 32,500 $0.00 $0.00
Disclosure

SEC source: 0002035815-26-000002 · wk-form4_1782504439.xml · nonDerivative · entry 1

KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,500

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.

Read SEC document
June 26, 2026 Filed Jul 24, 2026 20:32 UTC Amendment
KRULIK DOUGLASCAO and Interim CFO
GrantPerformance Share Units · Derivative 32,500 $0.00 $0.00
Disclosure

SEC source: 0002035815-26-000004 · wk-form4a_1784925161.xml · derivative · entry 2

KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 32,500 shares

Expires 2028-03-31

F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028.

F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028.

Read SEC document
June 26, 2026 Filed Jul 24, 2026 20:32 UTC Amendment
KRULIK DOUGLASCAO and Interim CFO
GrantCommon Stock 32,500 $0.00 $0.00
Disclosure

SEC source: 0002035815-26-000004 · wk-form4a_1784925161.xml · nonDerivative · entry 1

KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,500

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.

Read SEC document
June 08, 2026 Filed Jun 9, 2026 21:06 UTC PurchaseCommon Stock 25,000 $1.75 $43,725.00
Disclosure

SEC source: 0001213900-26-066871 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,600,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $1.72 to $1.75, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,875,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 725,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
January 21, 2026 Filed Jan 23, 2026 21:37 UTC
FULGONI GIANDirector
Disposition to issuerCommon Stock 26,057 $0.00 $0.00
Disclosure

SEC source: 0001040130-26-000004 · wk-form4_1769204244.xml · nonDerivative · entry 1

FULGONI GIAN · CIK 0001254384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,299

F1 · shares: This Form 4 is being filed to reflect the automatic forfeiture, in accordance with the applicable award agreement, of a portion of the restricted shares granted on October 30, 2025 to the reporting person due to the termination of director service by the reporting person as of January 21, 2026.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:08 UTC
KRULIK DOUGLASCAO and Interim CFO
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0002035815-25-000011 · wk-form4_1762204117.xml · nonDerivative · entry 1

KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on October 30, 2026, and 50% on October 30, 2027, subject to continued employment through each such vesting date.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:07 UTC
LaCamp JamesDirector
GrantCommon Stock 34,866 $0.00 $0.00
Disclosure

SEC source: 0001040130-25-000081 · wk-form4_1762204049.xml · nonDerivative · entry 1

LaCamp James · CIK 0001794194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,866

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan , of which 1,020 shares will vest on October 19, 2026 and 33,846 shares will vest on October 30, 2026, subject to continued service on the Board of Directors.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:06 UTC GrantCommon Stock 33,846 $0.00 $0.00
Disclosure

SEC source: 0001789515-25-000003 · wk-form4_1762203990.xml · nonDerivative · entry 1

Mennen Justin L. · CIK 0001789515 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,719

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:06 UTC
Solivan LeahDirector
GrantCommon Stock 33,846 $0.00 $0.00
Disclosure

SEC source: 0002028705-25-000004 · wk-form4_1762203958.xml · nonDerivative · entry 1

Solivan Leah · CIK 0002028705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,289

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:05 UTC GrantCommon Stock 33,846 $0.00 $0.00
Disclosure

SEC source: 0002064538-25-000002 · wk-form4_1762203913.xml · nonDerivative · entry 1

Batushansky Peter · CIK 0002064538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,373

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors.

Read SEC document
October 30, 2025 Filed Nov 14, 2025 22:26 UTC
FULGONI GIANDirector
GrantCommon Stock 33,846 $0.00 $0.00
Disclosure

SEC source: 0001040130-25-000088 · wk-form4_1763159178.xml · nonDerivative · entry 1

FULGONI GIAN · CIK 0001254384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,356

F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on October 30, 2026, subject to continued service on the Board of Directors.

Read SEC document
September 09, 2025 Filed Sep 11, 2025 20:34 UTC
KRULIK DOUGLASChief Accounting Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0002035815-25-000009 · wk-form4_1757622875.xml · nonDerivative · entry 1

KRULIK DOUGLAS · CIK 0002035815 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · acquired: Restricted stock award granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan (the "2024 Omnibus Plan"). The award will vest in its entirety on the 6-month anniversary of the grant date so long as Mr. Krulik remains on such date employed by the Company or otherwise in the service of the Company (as a director, consultant, or otherwise) and the award will vest in full in the event that the Company terminates the service by Mr. Krulik with the Company prior to the full vesting of the award unless such termination is for Cause (within the meaning 2024 Omnibus Plan).

Read SEC document
August 13, 2025 Filed Aug 14, 2025 12:40 UTC PurchaseCommon Stock, par value $0.001 101,000 $3.17 $320,170.00
Disclosure

SEC source: 0001903596-25-000404 · ownership.xml · nonDerivative · entry 1

Silvercape Investments Ltd · CIK 0002059711 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,579,696

Read SEC document
August 01, 2025 Filed Aug 4, 2025 12:26 UTC PurchaseCommon Stock, par value $0.001 118,200 $3.21 $379,422.00
Disclosure

SEC source: 0001903596-25-000383 · ownership.xml · nonDerivative · entry 1

Silvercape Investments Ltd · CIK 0002059711 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,478,696

Read SEC document
July 21, 2025 Filed Jul 22, 2025 20:15 UTC PurchaseCommon Stock 25,000 $3.50 $87,425.00
Disclosure

SEC source: 0001213900-25-066628 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,575,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $3.4935 to $3.4999, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,875,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 700,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
July 18, 2025 Filed Jul 21, 2025 12:13 UTC PurchaseCommon Stock, par value $0.001 17,565 $3.23 $56,734.95
Disclosure

SEC source: 0001903596-25-000348 · ownership.xml · nonDerivative · entry 1

Silvercape Investments Ltd · CIK 0002059711 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,360,496

Read SEC document
July 17, 2025 Filed Jul 18, 2025 10:02 UTC PurchaseCommon Stock, par value $0.001 31,701 $3.15 $99,858.15
Disclosure

SEC source: 0001903596-25-000346 · ownership.xml · nonDerivative · entry 1

Silvercape Investments Ltd · CIK 0002059711 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,342,931

Read SEC document
July 02, 2025 Filed Jul 3, 2025 14:19 UTC PurchaseCommon Stock, par value $0.001 2,817 $3.22 $9,070.74
Disclosure

SEC source: 0001903596-25-000330 · ownership.xml · nonDerivative · entry 1

Silvercape Investments Ltd · CIK 0002059711 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,311,230

Read SEC document
July 01, 2025 Filed Jul 2, 2025 18:41 UTC PurchaseCommon Stock, par value $0.001 694 $3.21 $2,227.74
Disclosure

SEC source: 0001903596-25-000329 · ownership.xml · nonDerivative · entry 1

Silvercape Investments Ltd · CIK 0002059711 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,308,413

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:15 UTC PurchaseCommon Stock 25,000 $3.94 $98,375.00
Disclosure

SEC source: 0001213900-25-051165 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,550,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $3.90 to $3.97, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,875,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 675,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
May 21, 2025 Filed May 23, 2025 20:15 UTC PurchaseCommon Stock 25,000 $3.86 $96,500.00
Disclosure

SEC source: 0001213900-25-047347 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,525,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $3.83 to $3.89, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,875,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 650,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
May 20, 2025 Filed May 22, 2025 14:55 UTC PurchaseCommon Stock, par value $0.001 7,401 $3.95 $29,233.95
Disclosure

SEC source: 0001903596-25-000291 · ownership.xml · nonDerivative · entry 1

Silvercape Investments Ltd · CIK 0002059711 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,307,719

Read SEC document
April 30, 2025 Filed May 3, 2025 00:57 UTC
Campos Sandra YvetteDirector · CEO & President
SaleCommon Stock 1,565 $3.33 $5,214.42
Disclosure

SEC source: 0001040130-25-000023 · wk-form4_1746233871.xml · nonDerivative · entry 2

Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 578,524

F1 · kind: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025.

F1 · shares: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025.

F2 · balance_after: Includes 473,834 restricted stock units ("RSUs") that are subject to vesting in accordance with the applicable RSU award agreements.

Read SEC document
April 30, 2025 Filed May 3, 2025 00:57 UTC
Campos Sandra YvetteDirector · CEO & President
SaleCommon Stock 58,898 $3.31 $194,875.81
Disclosure

SEC source: 0001040130-25-000023 · wk-form4_1746233871.xml · nonDerivative · entry 1

Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,089

F1 · kind: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025.

F1 · shares: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025.

Read SEC document
April 09, 2025 Filed Apr 11, 2025 20:17 UTC GrantCommon Stock 2,527 $0.00 $0.00
Disclosure

SEC source: 0001040130-25-000020 · wk-form4_1744402634.xml · nonDerivative · entry 1

Batushansky Peter · CIK 0002064538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,527

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") Non-Employee Director Equity Compensation Program, which vest on April 9, 2026, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

Read SEC document
March 18, 2025 Filed Mar 19, 2025 20:19 UTC PurchaseCommon Stock 100,000 $4.09 $408,500.00
Disclosure

SEC source: 0001213900-25-025088 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.08 to $4.09, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,875,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 625,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:15 UTC PurchaseCommon Stock 100,000 $4.11 $411,000.00
Disclosure

SEC source: 0001213900-25-022741 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,400,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.09 to $4.13, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,775,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 625,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:16 UTC PurchaseCommon Stock 50,000 $4.33 $216,250.00
Disclosure

SEC source: 0001213900-25-020199 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,300,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.29 to $4.36, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,675,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 625,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 23:01 UTC PurchaseCommon Stock 25,000 $4.82 $120,500.00
Disclosure

SEC source: 0001213900-25-010162 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,250,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.81 to $4.83, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,625,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 625,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
January 27, 2025 Filed Jan 28, 2025 21:15 UTC PurchaseCommon Stock 25,000 $4.64 $115,875.00
Disclosure

SEC source: 0001213900-25-007551 · ownership.xml · nonDerivative · entry 2

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,225,000

F3 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.60 to $4.67, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F4 · balance_after: Includes (i) 1,625,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 600,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
January 24, 2025 Filed Jan 28, 2025 21:15 UTC PurchaseCommon Stock 25,000 $4.95 $123,675.00
Disclosure

SEC source: 0001213900-25-007551 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,200,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.9283 to $4.9648, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,625,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 575,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
January 15, 2025 Filed Jan 18, 2025 00:00 UTC
Campos Sandra YvetteDirector · CEO & President
GrantPerformance Share Units · Derivative 146,772 $0.00 $0.00
Disclosure

SEC source: 0001040130-25-000004 · wk-form4_1737158449.xml · derivative · entry 2

Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,772

Underlying: Common Stock · 146,772 shares

Expires 2027-12-31

F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2027.

F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2027.

Read SEC document
January 15, 2025 Filed Jan 18, 2025 00:00 UTC
Campos Sandra YvetteDirector · CEO & President
GrantCommon Stock 146,772 $0.00 $0.00
Disclosure

SEC source: 0001040130-25-000004 · wk-form4_1737158449.xml · nonDerivative · entry 1

Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 638,987

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of January 15, 2025, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 21:09 UTC
Smith Jacqueline PaulaVice President of People
GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001040130-25-000002 · wk-form4_1737148164.xml · nonDerivative · entry 1

Smith Jacqueline Paula · CIK 0001906429 · Vice President of People

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,099

F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of January 15, 2025, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:05 UTC PurchaseCommon Stock 25,000 $4.98 $124,375.00
Disclosure

SEC source: 0001213900-25-002645 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,175,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.9538 to $4.9963, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,625,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 550,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:15 UTC PurchaseCommon Stock 32,000 $5.66 $180,960.00
Disclosure

SEC source: 0001213900-24-110154 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,150,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $5.6213 to $5.6926, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,600,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 550,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
December 06, 2024 Filed Dec 10, 2024 21:15 UTC PurchaseCommon Stock 40,000 $5.55 $222,000.00
Disclosure

SEC source: 0001213900-24-107425 · ownership.xml · nonDerivative · entry 1

NINA CAPITAL HOLDINGS INC. · CIK 0002040747 · 10% owner

TACHE GALANTE MOISES · CIK 0002041727 · 10% owner

MATZ ZYMAN STEPHANNIE · CIK 0002041725 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,118,000

F1 · price: The sales price reported is the weighted average sale price for the number of shares of Common Stock purchased. These shares were purchased in multiple transactions at prices ranging from $5.48 to $5.62, inclusive. Full information regarding the number of shares purchased at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F2 · balance_after: Includes (i) 1,590,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 528,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 02:06 UTC PurchaseCommon Stock 5,000 $5.46 $27,300.00
Disclosure

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 11

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Leslie C.G. Campbell 2020 Irrevocable Trust

Disclosed balance after: 30,000

F6 · ownership.nature: These shares are held in a trust for the benefit of the family members of the reporting person. The spouse of the reporting person is trustee of the trust, but the reporting person is not a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 02:06 UTC PurchaseCommon Stock 5,000 $5.45 $27,250.00
Disclosure

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 10

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Leslie C.G. Campbell 2020 Irrevocable Trust

Disclosed balance after: 25,000

F6 · ownership.nature: These shares are held in a trust for the benefit of the family members of the reporting person. The spouse of the reporting person is trustee of the trust, but the reporting person is not a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 02:06 UTC PurchaseCommon Stock 5,000 $5.42 $27,100.00
Disclosure

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 9

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Leslie C.G. Campbell 2020 Irrevocable Trust

Disclosed balance after: 20,000

F6 · ownership.nature: These shares are held in a trust for the benefit of the family members of the reporting person. The spouse of the reporting person is trustee of the trust, but the reporting person is not a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 02:06 UTC PurchaseCommon Stock 5,000 $5.41 $27,028.50
Disclosure

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 6

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

F5 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $5.4050 to $5.4086. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 02:06 UTC PurchaseCommon Stock 5,000 $5.44 $27,209.50
Disclosure

SEC source: 0001040130-24-000124 · wk-form4_1733537194.xml · nonDerivative · entry 5

Campbell Leslie C.G. · CIK 0001686078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

F4 · price: Reflects the weighted average purchase price. The range of prices for such transaction is $5.395 to $5.460. Open market purchase transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within the price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.